VREOD Stock Chart & Stats
$0.41
$0.02(3.15%)
At close: 4:00 PM EST
$0.41
$0.02(3.15%)
Day’s Range― - ―
52-Week Range$8.91 - $24.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)192.61K
Market Cap
$485.14M
Enterprise Value$404.70M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta<0.01
Next Earnings
Aug 06, 2026EPS Estimate
0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding48,500,576
10 Day Avg. Volume100,700
30 Day Avg. Volume192,613
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.83
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)0.53
Revenue Forecast (FY)$451.59M
Vireo Growth News
VREOD FAQ
What was Vireo Growth’s price range in the past 12 months?
Vireo Growth lowest stock price was $8.91 and its highest was $24.00 in the past 12 months.
What is Vireo Growth’s market cap?
Vireo Growth’s market cap is $485.14M.
When is Vireo Growth’s upcoming earnings report date?
Vireo Growth’s upcoming earnings report date is Aug 06, 2026 which is in 35 days.
How were Vireo Growth’s earnings last quarter?
Vireo Growth released its earnings results on May 12, 2026. The company reported -$0.392 earnings per share for the quarter, missing the consensus estimate of $0.15 by -$0.542.
Is Vireo Growth overvalued?
According to Wall Street analysts Vireo Growth’s price is currently Overvalued.
Does Vireo Growth pay dividends?
Vireo Growth does not currently pay dividends.
What is Vireo Growth’s EPS estimate?
Vireo Growth’s EPS estimate is 0.17.
How many shares outstanding does Vireo Growth have?
Vireo Growth has 48,500,576 shares outstanding.
What happened to Vireo Growth’s price movement after its last earnings report?
Vireo Growth reported an EPS of -$0.392 in its last earnings report, missing expectations of $0.15. Following the earnings report the stock price went up 0.75%.
Which hedge fund is a major shareholder of Vireo Growth?
Currently, no hedge funds are holding shares in VREOD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vireo Growth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.17%
12-Months-Change
Fundamentals
Return on Equity
-47.54%
Trailing 12-Months
Asset Growth
235.25%
Trailing 12-Months
Company Description
Vireo Growth
Vireo Health International, Inc. is a holding company, which engages in the cultivation, production, and sale of medical cannabis. Its products include medical marijuana extracts in the form of oils, vaporizers, and capsules. The company was founded on November 23, 2004 and is headquartered in Minneapolis, MN.
VREOD Company Deck
VREOD Earnings Call
Q1 2026
0:00 / 0:00
Technical Analysis
1 Day
3 Days
1 Week
1 Month
NeutriSci International
―
ZYUS Life Sciences
―
Luff Enterprises
―
―
Hash Corporation
―
Ownership Overview
Options Prices
Currently, No data available
---


